The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Terrance McGuire

Terrance McGuire

Co-founder and General Partner
Polaris Venture Partners

Terry McGuire is a co-founder and general partner of Polaris Venture Partners based in the Boston office. Terry focuses on life sciences investments. Prior to starting Polaris, Terry spent seven years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Terry began his career in venture capital at Golder, Thoma and Cressey in Chicago.

Terry has co-founded three companies: Inspire Pharmaceuticals, AIR (Advanced Inhalation Research, Inc.), and MicroCHIPS. Terry represents Polaris on the boards of directors of Acceleron Pharma, Adimab, Arsenal Medical, Inc., deCODE Genetics, Ironwood Pharmaceuticals, Life Line Screening, MicroCHIPS, Inc., Pulmatrix Inc., SustainX Energy Storage Solutions, and Trevena Inc. He has also served on the boards of Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, GlycoFi, Transform Pharmaceuticals, and Remon Medical Technologies. Terry is Chairman Emeritus of the National Venture Capital Association, which represents ninety percent of the venture capitalists in the United States. He served as Chairman from 2009-2010. He chairs the Board of Overseers of the Thayer School of Engineering, Dartmouth College, and serves on the boards of MIT's David Koch Institute for Integrative Cancer Research, and the Arthur Rock Center for Entrepreneurship, Harvard Business School.

Terry received his MBA from Harvard Business School, his MS in engineering from The Thayer School at Dartmouth College and his BS in physics and economics from Hobart College.

Terry is a recipient of the 2009 Massachusetts Society for Medical Research Award, and the 2005 Albert Einstein Award for Outstanding Achievement in the Life Sciences, awarded by Forbes/Gottlieb Medical Technology Investor, Harvard MIT Biomedical Engineering Center, the New Jerusalem Foundation, the Jerusalem Development Authority, and Rodman and Renshaw.